Clinical trial

Safety and Efficacy Study of Tranilast in Patients With Active Rheumatoid Arthritis (RA)

NCT00882024

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Tranilast Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Safety and Efficacy Study of Tranilast in Patients With Active Rheumatoid Arthritis (RA)

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2009-03-01

PhasePHASE2

Conditions

Active Rheumatoid Arthritisunresolved

Interventions

TranilastDRUG

PlaceboDRUG

Sponsors & collaborators

Nuon Therapeutics, Inc.lead sponsor

Mapped research locations

LondonUnited Kingdom1 San DiegoCalifornia, United States1 HamburgGermany1 PragueCzechia1 La JollaCalifornia, United States1 SofiaBulgaria1 BelgradeSerbia1 PlovdivBulgaria1 GuadalajaraJalisco, Mexico1 LansingMichigan, United States1 RosarioSanta Fe Province, Argentina1 AventuraFlorida, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00882024 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.